Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
Everest Group (EG)
NYSEFinancialsInsurance - ReinsuranceSnapshot 2026-10-15
$389.10+2.03%
Close 2026-10-16 · 1-day change
NYSEFinancialsInsurance - ReinsuranceSnapshot 2026-10-15
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
60.02 → 60.11 EPS · FY ending Dec 31, 2027 · 9 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Sep 15, 2026 to Oct 15, 2026: (new ÷ prior − 1). Contributor count changed from 9 to 9; this is not the number of analysts revising. Source: FMP consensus snapshots. The ±10% axis is a display range.
Living Fair Value by QuarterlyIQ
A valuation that evolves as the business changes.
A published Living FV snapshot is not available yet. The valuation workflow remains discoverable; a market target cannot supply the missing evidence.
View Living FV report and workflowThree key conditions need to be met for the investment thesis to play out.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Share repurchases of at least $331 million in Q1 2026 | Everest Group buys back $331 million in shares, showing strong capital return. | Intact | share repurchases fall below $331 million in Q1 2026 | Required source inputs unavailable Cannot calculate Share repurchases from the available matching source inputs. Missing inputs are not treated as zero. Source date unavailableLast status assessment Oct 15, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated as a priority in 6 of last 6 quarters. Everest repurchased $395 million in 2026-Q2 and $331 million in 2026-Q1, with consistent dividends of $2.00 per share across these quarters. Management has reiterated capital return focus each quarter and the trajectory is delivering with substantial share repurchases and stable dividends. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Oct 28, 2026
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This investment represents a turnaround story with a focus on improving fundamentals. The current thesis state is cautious, as recent financial results have been weak, but management is committed to capital returns and underwriting discipline.
The market seems to have priced in a cheap valuation compared to peers, with expectations slightly below the average. There is a low fragility tier, indicating that the stock is not overly sensitive to immediate market shocks.
Management has shown a commitment to returning capital to shareholders and improving underwriting discipline, though recent performance has been weak. The near-term risk of missing earnings is low, but there is a history of deep misses that warrants attention.
The long-term thesis hinges on management's ability to maintain capital returns and improve underwriting performance. Additionally, the performance of sector bellwethers and the Federal Reserve's interest rate decisions will significantly impact EG's trajectory.
In the next 1 to 3 years, EG's performance will depend on management execution and external market conditions. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
EPS near $16.1 to $16.2 per share for full year 2026 | A primary condition in Everest Group's published investment case. The stated target is >=16.08 USD per share. | Intact | EPS falls below $16.08 per share in 2026 | Diluted EPS: $14.22 per share FY2026-Q2; GAAP. Published target: >=16.08 USD per share. Target period ends 2026-12-31; this observation covers 2026-Q2. Source published Aug 3, 202614.22 USD/share · source valueSource reportLast status assessment Oct 15, 2026Measurement sourceconsolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 69caf34c-1f3d-4f48-81a0-a22f7629fed9. Source status: eligible. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Gross written premiums growth of at least 1.6% in Global Wholesale & Specialty | It grew premiums 1.6% in Global Wholesale & Specialty markets. | Intact | premium growth falls below 1.6% YoY in 2026-Q1 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 15, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$60.15 → $60.11 · observed estimates
Unavailable → $14.24B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $60.15 | Unavailable | 9 / 4 |
| 2026-07-25 | $60.45 | $13,178,800,000 | 15 / 5 |
| 2026-07-26 | $60.15 | Unavailable | 9 / 4 |
| 2026-07-27 | $60.15 | Unavailable | 9 / 4 |
| 2026-07-28 | $60.15 | Unavailable | 9 / 4 |
| 2026-07-29 | $60.45 | $13,178,800,000 | 15 / 5 |
| 2026-07-30 | $59.95 | Unavailable | 9 / 4 |
| 2026-07-31 | $60.08 | $13,178,800,000 | 15 / 5 |
| 2026-08-01 | $59.95 | Unavailable | 9 / 4 |
| 2026-08-02 | $60.08 | $12,739,066,670 | 14 / 6 |
| 2026-08-03 | $60.02 | Unavailable | 9 / 4 |
| 2026-08-04 | $60.08 | $12,739,066,670 | 14 / 6 |
| 2026-08-05 | $60.02 | Unavailable | 9 / 4 |
| 2026-08-06 | $60.08 | $12,739,066,670 | 14 / 6 |
| 2026-08-07 | $60.02 | Unavailable | 9 / 4 |
| 2026-08-08 | $60.17 | $12,524,733,330 | 14 / 6 |
| 2026-08-09 | $60.17 | $12,524,733,330 | 14 / 6 |
| 2026-08-10 | $60.02 | Unavailable | 9 / 4 |
| 2026-08-11 | $60.02 | Unavailable | 9 / 4 |
| 2026-08-12 | $59.95 | $12,374,485,710 | 14 / 7 |
| 2026-08-13 | $60.02 | Unavailable | 9 / 4 |
| 2026-08-14 | $60.02 | Unavailable | 9 / 4 |
| 2026-08-15 | $60.02 | $15,099,823,075 | 9 / 5 |
| 2026-08-16 | $60.02 | $15,099,823,075 | 9 / 5 |
| 2026-08-17 | $60.02 | $15,099,823,075 | 9 / 5 |
| 2026-08-18 | $60.02 | $15,099,823,075 | 9 / 5 |
| 2026-08-19 | $60.02 | $15,099,823,075 | 9 / 5 |
| 2026-08-20 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-08-21 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-08-22 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-08-23 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-08-24 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-08-25 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-08-26 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-08-27 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-08-28 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-08-29 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-08-30 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-08-31 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-09-01 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-09-02 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-09-03 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-09-04 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-09-05 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-09-06 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-09-07 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-09-08 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-09-09 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-09-10 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-09-11 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-09-12 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-09-13 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-09-14 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-09-15 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-09-16 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-09-17 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-09-18 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-09-19 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-09-20 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-09-21 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-09-22 | $60.02 | $14,403,206,701 | 9 / 6 |
| 2026-09-23 | $60.02 | $14,418,586,031 | 9 / 6 |
| 2026-09-24 | $60.02 | $14,418,586,031 | 9 / 6 |
| 2026-09-25 | $60.02 | $14,418,586,031 | 9 / 7 |
| 2026-09-26 | $60.02 | $14,418,586,031 | 9 / 7 |
| 2026-09-27 | $60.02 | $14,418,586,031 | 9 / 7 |
| 2026-09-28 | $60.02 | $14,418,586,031 | 9 / 7 |
| 2026-09-29 | $60.02 | $14,418,586,031 | 9 / 7 |
| 2026-09-30 | $60.02 | $14,418,586,031 | 9 / 7 |
| 2026-10-01 | $60.02 | $14,418,586,031 | 9 / 7 |
| 2026-10-02 | $60.10 | $14,418,586,031 | 10 / 6 |
| 2026-10-03 | $60.09 | $14,418,586,031 | 10 / 6 |
| 2026-10-04 | $60.09 | $14,418,586,031 | 10 / 6 |
| 2026-10-05 | $60.09 | $14,418,586,031 | 10 / 6 |
| 2026-10-06 | $60.08 | $14,424,654,159 | 10 / 6 |
| 2026-10-07 | $59.97 | $14,398,223,836 | 10 / 6 |
| 2026-10-08 | $59.91 | $14,227,123,836 | 10 / 6 |
| 2026-10-09 | $59.95 | $14,227,123,836 | 10 / 6 |
| 2026-10-10 | $59.95 | $14,227,123,836 | 10 / 6 |
| 2026-10-11 | $59.95 | $14,227,123,836 | 10 / 6 |
| 2026-10-12 | $59.95 | $14,227,123,836 | 10 / 6 |
| 2026-10-13 | $60.11 | $14,237,549,836 | 10 / 6 |
| 2026-10-14 | $60.11 | $14,237,549,836 | 9 / 6 |
| 2026-10-15 | $60.11 | $14,237,549,836 | 9 / 5 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 7 Buy / Strong Buy · 10 Hold · 0 Sell / Strong Sell
Recent actions · Sep 16–Oct 15 · 2 recorded
0 raises · 1 cuts · 0 unchanged · 2 without a comparable prior
Sep 16, 2026–Oct 15, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.